search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Colonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.


- candidate number1206
- NTR NumberNTR125
- ISRCTNISRCTN01790428
- Date ISRCTN created20-dec-2005
- date ISRCTN requested18-okt-2005
- Date Registered NTR22-aug-2005
- Secondary IDs1206 
- Public TitleColonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.
- Scientific TitleColonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.
- ACRONYMStent-in I study
- hypothesisPatient with incurable disseminated left-sided colonic cancer are better palliated by colonic stenting than surgery measured by hospital free survival in "good health"(WHO-score 0 or 1) Colonic stenting is cost effective in patients with incurable disseminated left-sided colonic cancer.
- Healt Condition(s) or Problem(s) studiedTumour, Colonic cancer
- Inclusion criteria1. Left sided colonic cancer (from left flexure to > 10 cm of anus);
2. Diagnosis histological proven;
3. No signs of double tumor;
4. Informed consent.
- Exclusion criteria1. Potentially curable disease;
2. ASA IV or V;
3. Ileus;
4. Karnofsky index of < 50%.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type[default]
- Studytypeintervention
- planned startdate 1-dec-2004
- planned closingdate1-jan-2008
- Target number of participants180
- InterventionsSurgical palliation versus "wait and see" policy and colonic stenting if obstruction is imminent.
- Primary outcome1. Total hospital free survival in good health (corrected for days with a WHO performance status > 1);
2. Integral costs (product of volume consumed care and prices of means (personnel, overhead, material and investments).
- Secondary outcome1. Procedural related hospital stay and mortality and morbidity;
2. Efficacy of palliation of (imminent) obstruction (complaints, secondary operation or stent placement);
3. Quality of life.
- Timepoints
- Trial web sitehttp://www.stent-in.nl
- statusstopped
- CONTACT FOR PUBLIC QUERIESMD. Jeanin Hooft, van
- CONTACT for SCIENTIFIC QUERIESProf. Dr. W.A. Bemelman
- Sponsor/Initiator Academic Medical Center (AMC), Department of Hepato- and Gastroenterology
- Funding
(Source(s) of Monetary or Material Support)
ZON-MW, The Netherlands Organization for Health Research and Development
- PublicationsEndoscopy(begin 2008) Stent-in I study
- Brief summarySurvival in patients with incurable colonic cancer is poor and is estimated at 9 months.
Morbidity associated with surgery might jeopardize successful palliation of imminent obstruction and bleeding. After hospital discharge the patient has to recover from surgery and might not reach the preoperative condition anymore due to postoperative morbidity or progressive disease. Patients who had successful colonic stenting recover very quickly from the endoscopic procedure. However, little is known how effective palliative stenting is in terms of long term relief of obstructing symptoms and early and late procedural morbidity and mortality.
The object of this study is to compare palliative treatment of (imminent) left sided obstruction in incurable colonic cancer either by surgery or colonic stenting.
Primary efficacy parameters are hospital free survival in good health (corrected for performance status) and integral costs. Based on a mean survival of 40 + 6 weeks and a difference in hospital free survival in good health of 3 weeks in favour of colonic stenting a total of 170 patients have to be included.
- Main changes (audit trail)
- RECORD21-aug-2005 - 10-dec-2007


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl